Akadēmiskais centrsStarptautiski citētās publikācijas
Pasaules mēroga citēšanas indeksu sarakstos (PubMed, Scopus, Web of Science, Google Scholar u. c.) publicētie zinātniskie raksti
1. Bornschein J, Tran-Nguyen T, Fernandez-Esparrach G, Ash S, Balaguer F, Bird-Lieberman E, et al. Biopsy sampling in upper gastrointestinal endoscopy - a survey from ten tertiary referral centres across Europe. Digestive Diseases. 2020.
2. Dekante A, Daugule I, Pavlovics S, Kikuste I, Polaka I, Tzivian L, et al. Low Prevalence of Celiac Disease among Patients with Functional Gastrointestinal Disorders in Latvia. Journal of gastrointestinal and liver diseases: JGLD. 2020;29(1):33-9.
3. Gasenko E, Leja M, Polaka I, Hegmane A, Murillo R, Bordin D, et al. How do international gastric cancer prevention guidelines influence clinical practice globally? Eur J Cancer Prev. 2020.
4. Guazzi P, Zocco D, Isajevs S, Zarovni N, Bianciardi L, Toots M, et al. TM9SF4 expression in tumor tissues: a novel diagnostic biomarker for gastrointestinal tumors. Transl Cancer Res. 2020;In Press.
5. Gudra D, Pupola D, Skenders G, Leja M, Radovica-Spalvina I, Gorskis H, et al. Lack of significant differences between gastrointestinal tract microbial population structure of Helicobacter pylori-infected subjects before and 2 years after a single eradication event. Helicobacter. 2020;25(5):e12748.
6. Gunnarsson Payne J, Korolczuk E, Mezinska S. Surrogacy relationships: a critical interpretative review. Ups J Med Sci. 2020;125(2):183-91.
7. Herrero R, Heise K, Acevedo J, Cook P, Gonzalez C, Gahona J, et al. Regional variations in Helicobacter pylori infection, gastric atrophy and gastric cancer risk: The ENIGMA study in Chile. PloS one. 2020;15(9):e0237515.
8. Leja M, Dumpis U. What Would the Screen-and-Treat Strategy for Helicobacter pylori Mean in Terms of Antibiotic Consumption? Dig Dis Sci. 2020;65(6):1632-42.
9. Matysiak-Budnik T, Constanza Camargo M, Blanca Piazuelo M, Leja M. Recent Guidelines on the Management of Patients with Gastric Atrophy: Common Points and Controversies. Dig Dis Sci. 2020.
10. Mezinska S, Kaleja J, Mileiko I, Santare D, Rovite V, Tzivian L. Public awareness of and attitudes towards research biobanks in Latvia. BMC Med Ethics. 2020;21(1):65.
11. Mezinska S, Kaleja J, Mileiko I. Becoming and being a biobank donor: The role of relationships and ethics. PLoS One. 2020;15(11):e0242828.
12. Mezmale L, Coelho LG, Bordin D, Leja M. Review: Epidemiology of Helicobacter pylori. Helicobacter. 2020;25 Suppl 1:e12734.
13. Mezmale L, Coelho LG, Bordin D, Leja M. Review: Epidemiology of Helicobacter pylori. Helicobacter. 2020;25 Suppl 1:e12734.
14. Nyssen OP, Bordin D, Tepes B, Perez-Aisa A, Vaira D, Caldas M, et al. European Registry on Helicobacter pylori management (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients. Gut. 2020.
15. Nyssen OP, Perez-Aisa A, Tepes B, Rodrigo-Saez L, Romero PM, Lucendo A, et al. Helicobacter pylori first-line and rescue treatments in patients allergic to penicillin: Experience from the European Registry on H pylori management (Hp-EuReg). Helicobacter. 2020:e12686.
16. Petkevicius V, Streleckiene G, Balciute K, Link A, Leja M, Malfertheiner P, et al. Association of Long Non-Coding RNA Polymorphisms with Gastric Cancer and Atrophic Gastritis. Genes (Basel). 2020;11(12).
17. Priede D, Roze B, Parshutin S, Arklina D, Pircher J, Vaska I, et al. Association between malocclusion and orofacial myofunctional disorders of pre-school children in Latvia. Orthod Craniofac Res. 2020;23(3):277-83.
18. Proboka G, Tilgase A, Isajevs S, Zablocka T, Olmane E, Rasa A, et al. Adrenal Gland and Gastric Malignant Melanoma without Evidence of Skin Lesion Treated with the Oncolytic Virus Rigvir. Case Rep Oncol. 2020;13(1):424-30.
19. Pumpure E, Drucka E, Kigitovica D, Meskauskas R, Isajevs S, Nemiro I, et al. Management of a primary malignant melanoma of uterine cervix stage IVA patient with radical surgery and adjuvant oncolytic virus Rigvir((R)) therapy: A case report. Clin Case Rep. 2020;8(8):1538-43.
20. Rajilic-Stojanovic M, Figueiredo C, Smet A, Hansen R, Kupcinskas J, Rokkas T, et al. Systematic review: gastric microbiota in health and disease. Aliment Pharmacol Ther. 2020.
21. Razuka-Ebela D, Polaka I, Parshutin S, Santare D, Ebela I, Murillo R, et al. Sociodemographic, Lifestyle and Medical Factors Associated with Helicobacter Pylori Infection. Journal of gastrointestinal and liver diseases: JGLD. 2020;29(3):319-27.
22. Razuka-Ebela D, Zile I, Tzivian L, Ebela I, Polaka I, Parshutin S, et al. Does Family History of Cancer Influence Undergoing Screening and Gastrointestinal Investigations? Journal of gastrointestinal and liver diseases : JGLD. 2020;29(4):523-8.
23. Robitaille A, Brancaccio RN, Dutta S, Rollison DE, Leja M, Fischer N, et al. PVAmpliconFinder: a workflow for the identification of human papillomaviruses from high-throughput amplicon sequencing. BMC Bioinformatics. 2020;21(1):233.
24. Salmane-Kulikovska I, Poplavska E, Mezinska S, Dumpe V, Dauvarte H, Lazdina L, et al. Medical, pharmacy and nursing students in the Baltic countries: interactions with the pharmaceutical and medical device industries. BMC Med Educ. 2020;20(1):105.
25. Streleckiene G, Inciuraite R, Juzenas S, Salteniene V, Steponaitiene R, Gyvyte U, et al. miR-20b and miR-451a Are Involved in Gastric Carcinogenesis through the PI3K/AKT/mTOR Signaling Pathway: Data from Gastric Cancer Patients, Cell Lines and Ins-Gas Mouse Model. Int J Mol Sci. 2020;21(3).
26. Wu W, Leja M, Tsukanov V, Basharat Z, Hua D, Hong W. Sex differences in the relationship among alcohol, smoking, and Helicobacter pylori infection in asymptomatic individuals. J Int Med Res. 2020;48(5):300060520926036.
27. Zodzika J, Krumina K, Jermakova I, Kojalo U, Plisko O, Santare D, et al. Post-reproductive aged women: a lost generation in the cervical cancer screening programme. Eur J Contracept Reprod Health Care. 2020:1-6.
Scopus / Web of Science / PubMed publicēšanai pieņemtie raksti
1. Leiherer A., Ślefarska D., Leja M., Heinzle C., Muendlein A., Kikuste I., Mezmale L., Drexel H., Mayhew C.A., Mochalski P. The volatilomic footprints of human HGC-27 andCLS-145 gastric cancer cell lines. Frontiers Molecular Biosciences (akceptēts). Automatic Control and Computer Science 1, 2021.
2. Leja M., Kortelainen J. M., Polaka I., Turppa E., Mitrovics J., Padilla M., Mochalski P., Shuster G., Pohle R., Kashanin D., Klemm R., Ikonen V., Mezmale L., Broza Y. Y., Shani G., Haick H., SNIFFPHONE project research group. Sensing gastric cancer via point-of-care sensor Breath Analyser. Cancer (akceptēts 16.12.2020.)
3. Mezmale L., Polaka I., Rudzite D., Vangravs R., Kikuste I., Parshutin S., Daugule I., Tazhedinov A., Belikhina T., Igissinov N., Young Park J., Herrero R., Leja M. Prevalence and potential risk factors of Helicobacter pylori infection among asymptomatic individuals in Kazakhstan. Asian Pacific Journal of Cancer Prevention (akceptēts 17.12.2020.)
4. Parshutin S. Kirshners A., Kornijenko Y., Zabiniako V., Gasparovica-Asite M., Rozkalns A. Classification with LSTM networks in unbalanced environment. Automatic Control and Computer Science (1. 2021.)
Nodaļas enciklopēdijās
1. Leja M., Chapelle N., Kikuste I., Fedorov E., Sivins A., Carneiro F., Matysiak-Budnik T. Gastric Cancer; Prevention and Treatment. Encyclopedia of Gastroenterology, 2nd Edition; 565-580. doi.org/10.1016/B978-0-12-801238-3.11317-0.
Vietējas nozīmes izdevumu raksti
1. Mežinska S., Rovīte V. Sabiedrības un ārstu iesaiste pētniecības biobanku veidošanā. Latvijas Ārsts (2020, februāris), 74.-77.lpp. ISSN 1019-5068
2. Švandere A., Mileiko I., Pētniecības biobanku izpētes rezultātu atgriešana: donoru skatījums. LU Studentu zinātniskās konferences " Homo et. Persona. Societas. Natura. Innovationes : rakstu krājums. Rīga: LU Akadēmiskais apgāds, 2020., 19-28.lpp.
Starptautiskos žurnālos publicētas tēzes
1. Aleksejeva J., Razuka-Ebela D, Daugule I, Polaka I, Parshutin S, Santare D, Ebela I, Murillo R, Herrero R, Young Park J, Leja M. H. pylori prevalence in individuals with allergic disease in the Latvian population. The Year in Helicobacter. XXXIIIrd International Workshop on Helicobacter & Microbiota in Inflammation & Cancer, Virtual Conference, 12 September 2020. Vol. 25, issue 21, p. 33.
2. Aleksejeva J., Razuka-Ebela D., Daugule I., Polaka I., Parshutin S., Santare D., Ebela I., Murillo R., Herrero R., Park J. Y., Leja M.. Decreased pepsinogen level in relation to presence of menopause in the GISTAR study population in Latvia. Medicina (Kaunas) Vol. 56, Suppl.1: International Scientific Conference on Medicine, 78th International Scientific Conference of the University of Latvia, Riga: Abstracts (2020):252.
3. Balčiūtė K., Inčiūraitė R., Petkevičius V., Streleckienė G., Leja M., Kupčinskas J., Skiecevičienė J. Single nucleotide variants in long non-coding RNAs ANRIL and H19 are associated with gastric cancer type and Helicobacter pylori. Medicina (Kaunas) 2020;56(Supplement 1):84
4. Baršuka A., Pudāne K., Tolmanis I., Vanags A., Stirna D., Sosāre L., Vilkoite I., Gulbe I., Roderte I., Leja M., Kikuste I., Distribution of patients with gastric precancerous lesions from january till june 2016 at digestive diseases center GASTRO, Abstracts of The 62nd International Scientific Conference of Daugavpils University, 70.
5. Bornschein J.; Tran-Nguyen T.; Ash S.; Fernandez-Esparrach G.; Balaguer F.; Bird-Lieberman E.; Córdova H.; Dzerve Z.; Fassan M.; Leja M.; Lyutakov I.; Middelburg T.; Moreira L.; Nakov R.; Nieuwenburg S.A.V.; O'Connor A.; Realdon S.; DeSchepper H.; Smet A.; Spaander M.C.; Tolmanis I.; Urbonas T.; Weigt J.; Hold G.; Link A.; Kupcinskas J. Endoscopic biopsy sampling during gastroscopy –Discrepancies across Europe. Helicobacter 25 Suppl 1, EP3.18
6. Bujanda L.; O.P.Nyssen; A.Cosme; D.Bordin; B.Tepes; A. Perez-Aisa; D.Vaira; M.Caldas; M.Castro-Fernandez; F.Lerang; M.Leja; L.Rodrigo; T.Rokkas; L.Kupcinskas; J.Perez-Lasala; L.Jonaitis; O.Shvets; A.Gasbarrini; H.Simsek; A.T.R Axon; G.Buzas; J.Machado; Y.Niv; L.Boyanova; A.Goldis; V.Lamy; A.Tonkic; W.Marlicz; C.Beglinger; M.Venerito; P.Bytzer; L.Capelle; T.Milosavljevic; L.Veijola; J.Molina-Infante; L.Vologhzanina; Impact of Helicobacter pylori clarithromycin resistance on the treatment effectiveness: Data of the European Registry on H. Pylori Management (Hp-EuReg). Helicobacter 25 Suppl 1, EP2.25
7. Bujanda L.; O.P.Nyssen; A.Cosme; D.Bordin; B.Tepes; A. Perez-Aisa; D.Vaira; M.Caldas; M.Castro-Fernandez; F.Lerang; M.Leja; L.Rodrigo; T.Rokkas; L.Kupcinskas; J.Perez-Lasala; L.Jonaitis; O.Shvets; A.Gasbarrini; H.Simsek; A.T.R Axon; G.Buzas; J.Machado; Y.Niv; L.Boyanova; A.Goldis; V.Lamy; A.Tonkic; W.Marlicz; C.Beglinger; M.Venerito; P.Bytzer; L.Capelle; T.Milosavljevic; L.Veijola; J.Molina-Infante; L.Vologhzanina; G.Fadeenko; I.Ariño; G.Fiorini; E.Resina; R.Muñoz; I.Puig; F.Megraud; C.O'Morain; J.P.Gisbert Helicobacter pylori antibiotic resistance: Data from the European Registry on H. pylori Management (Hp-EuReg). Helicobacter 25 Suppl 1, EP2.24
8. Bujanda L.; O.P.Nyssen; D.S.Bordin; A.Cosme; B.Tepes; A. Perez-Aisa; D.Vaira; M.Caldas; M.Castro-Fernandez; F.Lerang; M.Leja; L.Rodrigo; T.Rokkas; L.Kupcinskas; J. Perez-Lasala; L.Jonaitis; O.Shvets; A.Gasbarrini; H.Simsek; A.Axon; G.Buzas; J.Machado; Y.Niv; L.Boyanova; A.Goldis; V.Lamy; A.Tonkic; W.Marlicz;C. Beglinger; M.Venerito; P.Bytzer; L.Capelle; T.Milosavljevic; L.Veijola; J.Molina-Infante; L.Vologhzanina;G.Fadeenko; I.Ariño; G.Fiorini; E.Resina; R.Muñoz; I.Puig; F.Megraud; C.O'Morain; J.P.Gisbert Antibiotic resistance trends of Helicobacter pylori naïve patients in the period 2013-2019: Analysis of the European Registry on H. pylori Management (Hp-Eu- Reg) Helicobacter 25 Suppl 1, EP2.22
9. Caldas M.; Á.Pérez-Aisa; B.Tepes; M.Castro-Fernández; L.Bujanda; G.Fadeenko; A.J.Lucendo; D.Vaira; L.Jonaitis; N.Brglez Jurecic; J.Pérez-Lasala; L.Fernández-Salazar; L.Rodrigo; J.Huguet; M.Leja; M.Areia; J.Barrio; J.Ortuño; S.Alekseenko; J.Molina-Infante; P.Bogomolov; V.Ntouli; M.Domínguez-Cajal; R.Ruiz-Zorrilla; R.Pellicano; M.Espada; I.Puig; O.P.Nyssen; F.Megraud; C.O´Morain; J.P.Gisbert. Effectiveness of first-line H. pylori eradication therapy according to the daily statin-use: Analysis of the European Registry on H. pylori Management (Hp-EuReg). Helicobacter 25 Suppl 1, EP2.32
10. Denina A.; Erts R.; Sitikova I.; Polaka I.; Leja M. Comparison of glucose and lactulose breath test results for detecting small intestinal bacterial overgrowth. Helicobacter 25 Suppl 1, EP11.03
11. Fadeenko G.; I.Ariño; G.Fiorini; E.Resina; R.Muñoz; I.Puig; F.Megraud; C.O'Morain; J.P.Gisbert. Impact of Helicobacter pylori clarithromycin resistance on the treatment effectiveness: Data of the European Registry on H. Pylori Management (Hp-EuReg). Helicobacter 25 Suppl 1, EP2.25
12. Kalēja J., Mežinska S., Mileiko I. Donors’ perspective on research biobanking in Latvia: practical implications for involved professionals. Medicina (Kaunas) Nr.56, Suppl.1: Abstracts of the 78th International Scientific Conference of the University of Latvia Riga, Latvia (2020), p.61..
13. Lielause A.; O.Sjomina; A.Rūdule; J.Priedola; D.Pūpola; R.Vangravs; A.Kiršners; S.Paršutins; I.Poļaka; E.Cine; G.Šķenders; D.Ražuka-Ebela; M.Leja. The comparison of side effects and effectiveness of standard triple therapy with clarithromycin and alternative high-dose amoxicillin/bismuth therapy in eradication of H. Pylori. Helicobacter 25 Suppl 1, EP2.27
14. Mežinska S., Kalēja J., Mileiko I., Rovīte V., Šantare S., Tzivian L. Public attitudes towards research biobanks in Latvia. Medicina (Kaunas) Nr.56, Suppl.1: Abstracts of the 78th International Scientific Conference of the University of Latvia Riga, Latvia (2020), p.59.
15. Mezmale L., Polaka I., Kikuste I., Tolmanis I., Mitrovics J., Leja M. The ability of gold nanoparticles sensors and metal oxide sensors to differentiate gastric cancer patients from healthy individuals. Medicina (Kaunas) 2020;56(Supplement 1):254.
16. Mezmale L., Polaka I., Kikuste I., Tolmanis I., Zarkova K., Lescinska A., Padilla M., Mitrovics J., Leja M. Application of gold nanoparticles and metal oxide sensors for non-invasive detection of gastric cancer. XXXIIIrd International Workshop on Helicobacter & Microbiota in Inflammation & Cancer. Helicobacter 25 Suppl 1: 120, EP3.01, p.49, 2020
17. Mochalski P., Leiherer A., Heinzle C., Muendlein A., Ślefarska D., Mezmale L., Kikuste I., Tolmanis I., Shani G., Leja M., Haick H. In vitro profiling of volatile organic compounds released and consumed by CLS-145 and HGC-27 gastric cell lines. XXXIIIrd International Workshop on Helicobacter & Microbiota in Inflammation & Cancer. Helicobacter 25 Suppl 1: 126; EP 3.16, p.55, 2020.
18. Mochalski P., Mezmale L., Polaka I., Kikuste I., Vanags A., Tolmanis I., Veliks V., Leja M. Identification of volatile organic compounds emitted by gastric juice. XXXIIIrd International Workshop on Helicobacter & Microbiota in Inflammation & Cancer. Helicobacter 25 Suppl 1: 120, EP3.02, p.49, 2020.
19. Nyssen O. P.; Bordin D., Tepes B., Pérez-Aisa , Vaira D., Caldas M., Bujanda , Castro-Fernandez M., Lerang F., Leja M., Rodrigo L., Rokkas T., Kupcinskas L., Pérez-Lasala J., Jonaitis L., Shvets O., Gasbarrini A., Simsek H., Axon A.R.T., Buzás G.M., Machado J., Niv Y., Boyanova L., Goldis A., Lamy V., Tonkic A., Przytulski K., Beglinger C., Venerito M., Bytzer P., Capelle L.G., Milosavljevic T., Veijola L., Molina-Infante J., Vologzhanina L., Fadeenko G., Ariño I., Fiorini G., Garre A., Garrido J., Pérez C.F., Heluwaert F., Puig I., Mégraud F., O'Morain C., Gisbert J.P. European Registry on H. pylori Management (Hp-EuReg): Empirical first-line treatment use and effectiveness trends in Europe in the period 2013-2020. XXXIIIrd International Workshop on Helicobacter & Microbiota in Inflammation & Cancer. Helicobacter 25 Suppl 1, EP2.12, p. 15-17, 2020.
20. Nyssen O. P.; D. Bordin; B. Tepes; A. Pérez-Aisa; D. Vaira; M. Caldas; L. Bujanda; M. Castro-Fernandez; F. Frode Lerang; M. Leja; L. Rodrigo; T. Rokkas; L. Kupcinskas; J. Pérez-Lasala; L. Jonaitis; O. Shvets; A.Gasbarrini; H.Simsek; A.T.R Axon; G.M.Buzás; J.Machado; Y.Niv; L.Boyanova; A. Goldis; V.Lamy; A.Tonkic; K.Przytulski; C.Beglinger; M. Venerito; P.Bytzer; L.G.Capelle; T.Milosavljevic; V.Milivojevic; L.Veijola; J.Molina-Infante; L.Vologzhanina; G. Fadeenko; I.Ariño; G.Fiorini; A.Garre; J.Garrido; C.F.Pérez; F.Heluwaert; I.Puig; F.Mégraud; C.O'Morain; J.P.Gisbert. First-line H. pylori eradication therapy in Europe: Results from 24,882 cases of the European Registry on H. Pylori Management (Hp-EuReg). XXXIIIrd International Workshop on Helicobacter & Microbiota in Inflammation & Cancer. Helicobacter 25 Suppl 1, EP2.10, p. 12-13, 2020.
21. Nyssen O.P.; A.Pérez-Aísa; B.Tepes; D.Vaira; D.S.Bordin; O.Shvets; L.Kupcinskas; R.Marcos Pinto; M.Leja; N.Fernanadez-Moreno; I.Santaella; G.Fiorini; L.Vologzhanina; G.Fadeenko;L.Jonaitis; A.Lucendo; L.Bujanda; A.S.Sarsenbaeva; M.Areia; M.Caldas; A.Garre; I.Puig;F.Megraud; C.O'Morain; J.P.Gisbert; European Registry on H. pylori Management (Hp-EuReg): Analysis of empirical second-line treatments in Europe. XXXIIIrd International Workshop on Helicobacter & Microbiota in Inflammation & Cancer. Helicobacter 25 Suppl 1, EP2.13, 18-19, 2020.
22. Nyssen O.P.; L.Kupcinskas; B.Tepes; O.Shvets; D.Bordin; M.Leja; J.Carlos Machado; T.Rokkas; G.M Buzas; I.Simsekn; T.Axon; F.Lerang; L.Jonaitis; R.Muñoz; E.Resina; M.Espada; I.Puig; F.Megraud; C.O'Morain; J.P.Gisbert, Safety of the treatment of H. pylori infection: Experience from the European Registry on H. pylori Management (Hp-EuReg) on 22,000 patients. XXXIIIrd International Workshop on Helicobacter & Microbiota in Inflammation & Cancer. Helicobacter 25 Suppl 1, EP2.17, P. 23, 2020.
23. Polaka I., Viktors Veliks, Carsten Jaeschke, Marta Padilla, Martins Leja, Linda Mezmale, Ilze Kikuste, Jan Mitrovics, Marcis Leja, Hossam Haick. The impact of food consumption on sensor readings in a POC breath analysis device. Medicina (Kaunas) 2020; 56(Supplement 1):258
24. Razuka-Ebela D, Polaka I, Parshutin S, Santare D, Ebela I, Sjomina O, Murillo R, Herrero R, Young Park J, Leja M., Presence and severity of symptom-based gastroesophageal reflux disease associated with levels of pepsinogen. Medicina (Kaunas) Vol. 56, Suppl.1: International Scientific Conference on Medicine, 78th International Scientific Conference of the University of Latvia, Riga: Abstracts (2020):21.
25. Razuka-Ebela D., Polaka I., Parshutin S., Daugule I., Ebela I. Santare D., Sjomina O., Herrero R., Park J. Y., Leja M. Serologically determined gastric atrophy associated with lifestyle, dietary factors and Helicobacter pylori status. United European Gastroenterology Journal Vol.8, Suppl.8: 28th United European Gastroenterology Week Virtual 2020, Poster number P0193, p.228.
26. Razuka-Ebela D., Polaka I., Parshutin S., Daugule I., Ebela I., Santare D., Herrero R., Park J. Y., Leja M. Factors associated with gastric atrophy 'missed' by serologic testing. United European Gastroenterology Journal Vol.8, Suppl.8: 28th United European Gastroenterology Week Virtual 2020, Poster number P0197, p.230.
27. Savcenko S., Liepniece-Karele I., Bogdanova I., Isajevs S., Kikuste I., Vanags A, Dzērve Z, Tolmanis I., LejaM. Prevalence of low and high risk precancerous lesions in gastric mucosa. Medicina (Kaunas) Nr.56, Suppl.1:, 2020, p27.
28. Sorokins V., Tilgase A., Olmane E., Isajevs S., Zablocka T., Rasa A., Alberts A. A progressive stage IIIB melanoma treated with oncolytic ECHO-7 virus: A case report. SAGE Open Medical Case Reports Vol. 8 (2020), p.1-4.
29. Vangravs R., Daugule I., RudziteD., Benejat L., Mezmale L., Kikuste I., Inga Bogdanova, Altynbek Tazhedinov, Dmitry Mushinskiy, Darkhan Sametayev, Tatyana Belikhina, Nurbek Igissinov, Francis Megraud, Marcis Leja. H. pylori clarithromycin resistance: experience in Kazakhstan. Medicina (Kaunas) 2020;56(Supplement 1):83
Ziņojumi starptautiskās konferencēs
Mutiskie ziņojumi
1. Lielause A.; Sjomina O.; Rūdule A.; Priedola J.; Pūpola D.; Vangravs R.; Kiršners A.; Paršutins S.; Poļaka I.; Cine E.; Šķenders G.; Ražuka-Ebela D.; Leja M. The comparison of side effects and effectiveness of standard triple therapy with clarithromycin and alternative high-dose amoxicillin/bismuth therapy in eradication of H. Pylori. XXXIIIrd International Workshop on Helicobacter & Microbiota in Inflammation & Cancer, Virtual Conference September 12, 2020
2. Mežinska S., Autonomy and Solidarity in the Context of Research Biobanks: Results of a Study on Public Attitudes Towards Research Biobanks in Latvia” World Congress of Bioethics. (Tiešsaistē: 19.-21.06.2020)
3. Leja M., Denina A. Comparison of glucose and lactulose breath test results for detecting small intestinal bacterial overgrowth. European Helicobacter and Microbiota Study Group (XXXIIIrd EHMSG 2020 Virtual Conference, September 12, 2020)
4. Aleksejeva J., Razuka-Ebela D., Daugule I., Polaka I., Parshutin S., Santare D., Ebela I., Murillo R., Herrero R., Park J.Y., Leja M. H. pylori prevalence in individuals with allergic disease in the Latvian population. European Helicobacter and Microbiota Study Group (EHMSG 2020 Virtual Conference)
5. O. Sjomina, A. Lielause, A. Rūdule, E. Martinsone, D. Pūpola, R. Vangravs, A. Kiršners, S. Paršutins, H. Gorskis, I. Poļaka, A. Jeniceka, E. Cine1 G. Šķenders, D. Razuka-Ebela, M. Leja. The comparison of effectiveness of standard triple therapy and high-dose amoxicillin/ bismuth therapy in eradication of H. pylori (International Scientific Conference on Medicine, 78th International Scientific Conference of the University of Latvia, Riga)
6. Reinis Vangravs, Ilva Daugule, Dace Rudzite, Lucie Benejat, Linda Mezmale, Ilze Kikuste, Inga Bogdanova, Altynbek Tazhedinov, Dmitry Mushinskiy, Darkhan Sametayev, Tatyana Belikhina, Nurbek Igissinov, Francis Megraud, Marcis Leja. H. pylori clarithromycin resistance: experience in Kazakhstan (International Scientific Conference on Medicine, 78th International Scientific Conference of the University of Latvia, Riga)
7. Selga Savcenko, Inta Liepniece-Karele, Inga Bogdanova, Sergejs Isajevs, Ilze Kikuste, Aigars Vanags, Zane Dzērve, Ivars Tolmanis, Marcis Leja. The prevalence of low and high risk precancerous lesions in gastric mucosa (International Scientific Conference on Medicine, 78th International Scientific Conference of the University of Latvia, Riga)
Stenda referāti
1. Signe Mezinska , Mileiko I., Kaleja J., Santare D., Rovite V. Relational autonomy, ethics and sustainability of biobanks. Poster Num: PO-14. Europe Biobank Week congress 2020 (tiešsaistē:17-20.11.2020)
2. Rovite V., Peculis R., Santare D., Mezinska S. A survey of researchers concerns and needs regarding collaboration with biobanks in Latvia. Europe Biobank Week congress 2020 (tiešsaistē: 17-20.11.2020)
3. Casati S., Ellul B., Mezinska S., Budin-Ljsne I., Martin G.M., Tzotzartou O., Bentzen H.B. Mapping European RECs review processes for biobank-based research. Poster Num: PO-17. Europe Biobank Week congress 2020. (tiešsaistē: 17-20.11.2020)
4. Pawel Mochalski, Andreas Leiherer, Christine Heinzle, Axel Muendlein, Daria Ślefarska, Linda Mezmale, Ilze Kikuste, Ivars Tolmanis, Gidi Shani, Marcis Leja, Hossam Haick. In vitro profiling of volatile organic compounds released and consumed by CLS-145 and HGC-27 gastric cancer cell lines. European Helicobacter and Microbiota Study Group (XXXIIIrd EHMSG 2020 Virtual Conference | e-Poster Presentations, September 12, 2020)
5. L. Mezmale, I. Polaka, I. Kikuste, I. Tolmanis, K. Zarkova, A. Lescinska, M. Padilla, J. Mitrovics, M. Leja. Application of gold nanoparticles and metal oxide sensors for non-invasive detection of gastric cancer. European Helicobacter and Microbiota Study Group (XXXIIIrd EHMSG 2020 Virtual Conference | e-Poster Presentations, September 12, 2020)
6. P. Mochalski, L. Mezmale, I. Polaka, I. Kikuste, A. Vanags, I. Tolmanis, V. Veliks, M. Leja. Identification of volatile organic compounds emitted by gastric juice. European Helicobacter and Microbiota Study Group (XXXIIIrd EHMSG 2020 Virtual Conference | e-Poster Presentations, September 12, 2020)
7. Danute Razuka-Ebela, Inese Polaka, Sergei Parshutin, Ilva Daugule, Daiga Santare, Inguna Ebela, Rolando Herrero, Jin Young Park, Marcis Leja. Serologically determined gastric actrophy associated with lifestyle, dietary factors and Helicobacter pylori status (United European Gastroenterology Week (UEGW), Virtual Conference | e-Poster Presentations, October 11-13, 2020)
8. Danute Razuka-Ebela, Inese Polaka, Sergei Parshutin, Ilva Daugule, Daiga Santare, Inguna Ebela, Rolando Herrero, Jin Young Park, Marcis Leja. Factors associated with gastric atrophy „missed” by serologic testing. (United European Gastroenterology Week (UEGW), Virtual Conference | e-Poster Presentations, October 11-13, 2020)
9. P. Mochalski., L. Mezmale, I. Polaka, I. Kikuste, A.Vanags, I. Tolmanis, V. Veliks, M. Leja. Analysis of volatile organic compounds emitted by gastric juice (United European Gastroenterology Week (UEGW), Virtual Conference | e-Poster Presentations, October 11-13, 2020)
10. Jan Bornschein, Terry Tran-Nguyen, Gloria Fernandez-Esparrach, Stephen Ash, Francesc Balaguer, Elisabeth Bird-Lieberman, Henry Córdova, Zane Dzerve, Matteo Fassan, Marcis Leja, Ivan Lyutakov, Tim Middelburg, Leticia Moreira, Radislav Nakov, Stella A V Nieuwenburg, Anthony O'Connor, Stefano Realdon, Heiko DeSchepper, Annemieke Smet, M C W Spaander, Ivars Tolmanis, Tadas Urbonas, Jochen Weigt, Georgina L Hold, Alexander Link, Juozas Kupcinskas. Biopsy sampling in upper gastrointestinal endoscopy - a survey from ten tertiary referral centres across Europe (United European Gastroenterology Week (UEGW), Virtual Conference | e-Poster Presentations, October 11-13, 2020)
11. Lusheng Song, Minkyo Song, M. Constanza Camargo, Jennifer Van Duine, Stacy Williams, Yunro Chung, Kyoung-Mee Kim, Jolanta Lissowska, Sergejs Isajevs, Sung Kim, Weimin Gao, Kailash Karthikeyan, Jin Park, Marcis Leja, Jeffrey L. Cohen, Joshua LaBaer, Ji Qiu and Charles S. Rabkin. Elevated levels of anti-Epstein Barr virus (EBV) antibodies in EBV-associated gastric carcinoma (AACR 2020 Annual Meeting (American Association for Cancer Research, April 24 - 29, 2020, San Diego Convention Center, San Diego, California)
12. Jin Young Park, Inese Polaka, Sergei Parshutin, Ilze Kikuste, Sergejs Isajevs, Inta Liepniece-Karele, Ilva Daugule, Danute Ražuka-Ebela, Viktoria Knaze, Laura Downham, Raul Murillo, Rolando Herrero, Marcis Leja. Results from the Pilot study of the multicentre randomised trial of H. pylori eradication and pepsinogen testing for prevention of gastric cancer mortality (the GISTAR Pilot study). (3rd Seoul International Symposium on Helicobacter and Upper Gastrointestinal Diseases (SI-HUG 2020); July 17-18, 2020, Seoul, Korea)
13. Danute Razuka-Ebela, Inese Polaka, Sergei Parshutin, Daiga Santare, Inguna Ebela, Olga Sjomina, Raul Murillo, Rolando Herrero, Jin Young Park, Marcis Leja. Presence and severity of symptom-based gastroesophageal reflux disease associated with levels of pepsinogen. (International Scientific Conference on Medicine, 78th International Scientific Conference of the University of Latvia, Riga)
14. Danute Razuka-Ebela, Inese Polaka, Sergei Parshutin, Daiga Santare, Inguna Ebela, Rolando Herrero, Jin Young Park, Marcis Leja. Helicobacter pylori infection, cardiovascular disease and its risk factors in Latvia (International Scientific Conference on Medicine, 78th International Scientific Conference of the University of Latvia, Riga)
15. Inese Polaka, Viktors Veliks, Carsten Jaeschke, Marta Padilla, Martins Leja, Linda Mezmale, Ilze Kikuste, Jan Mitrovics, Marcis Leja, Hossam Haick. The impact of food consumption on sensor readings in a point-of-care breath analysis device (International Scientific Conference on Medicine, 78th International Scientific Conference of the University of Latvia, Riga)
16. Jelizaveta Aleksejeva, Danute Razuka-Ebela, Ilva Daugule, Inese Polaka, Sergei Parshutin, Daiga Santare, Inguna Ebela, Raul Murillo, Rolando Herrero, Jin Young Park, Marcis Leja. Decreased pepsinogen level in relation to presence of menopause in the GISTAR study population in Latvia (International Scientific Conference on Medicine, 78th International Scientific Conference of the University of Latvia, Riga)
17. Linda Mezmale, Inese Polaka, Ilze Kikuste, Ivars Tolmanis, Jan Mitrovics, Marcis Leja. The ability of gold nanoparticles sensors and metal oxide sensors to differentiate gastric cancer patients from healthy individuals (International Scientific Conference on Medicine, 78th International Scientific Conference of the University of Latvia, Riga)
18. Inese Polaka, Viktors Veliks, Carsten Jaeschke, Marta Padilla, Martins Leja, Linda Mezmale, Ilze Kikuste, Jan Mitrovics, Marcis Leja, Hossam Haick. The impact of food consumption on sensor readings in a POC breath analysis device (International Scientific Conference on Medicine, 78th International Scientific Conference of the University of Latvia, Riga)
19. Zane Dzerve, Ilze Kikuste, Aigars Vanags, Dans Stirna, Vilnis Sosars, Linda Sosare, Indra Gulbe, Ilona Vilkoite, Irita Roderte, Ivars Tolmanis, Marcis Leja. Low prevalence of Barrett`s esophagus (International Scientific Conference on Medicine, 78th International Scientific Conference of the University of Latvia, Riga)
Ziņojumi vietēja mēroga zinātniskajās konferencēs
1. Darija Logvinova "Symptoms and the time to diagnosis in patients with gastric and esophageal cancers" (Rīgas Stradiņa universitātes (RSU) studentu zinātniskā konference “Health and Social Sciences”)
Lekcijas, uzstāšanās starptautiskās organizācijās, semināros un pasākumos
1. Mārcis Leja. Referāts par kuņģa vēža epidemioloģiju un skrīninga iespējām (krievu val.) Pavlova vārdā nosauktās Pirmās St.Pēterburgas Valsts Medicīnas universitātes zinātniski-praktiskā konference par dažādiem kuņģa vēža aspektiem "Kuņģa vēzis - no "A" līdz "Z" ", Sanktpēterburga, Krievija, 07.02.2020.
2. Mārcis Leja. Lekcija par GISTAR pētījuma norisi Latvijā. Lekcija par Gaistošo marķieru diagnostikas projektiem kuņģa vēža noteikšanai. Maskavas klīniskās pētniecības centra un Gastroenteroloģijas centrālā zinātniski - pētnieciskā institūta kopēji organizētā 46. konference “Ģenētika gastroenteroloģijā – iespējas un perspektīvas". Maskava, Krievija, 27.-28.02.2020.
3. Eiropas Biobanku nedēļa (EBW) 2020. Piedalās LU KPMI pētnieki. Digitāls pasākums, 17.-20.11.2020.
Lekcijas, uzstāšanās vietēja mēroga organizācijās, semināros un pasākumos
1. Signe Mežinska. “Sabiedrības informētība un attieksme pret pētniecības biobankām Latvijā”. Seminārs “Pētniecības biobanku ētiski un sociāli atbildīga pārvaldība Baltijas valstīs”. Latvijas Universitāte, Rīga, 29.10.2020.
2. Mārcis Leja. Studentu biznesa iespēju festivāls Icebreakers'20. Diskusija “Biobankas un lielie dati”. Latvijas Universitāte, Rīga, 09.10.2020.
3. Ģirts Šķenders. TB agrīnā diagnostika (krievu val.). PVO sadarbības centrs, 28.09.2020.
4. Ģirts Šķenders. Genotipisko ZJT atjaunotā interpretācija (krievu val.). PVO sadarbības centrs, 28.09.2020.
5. Mārcis Leja. Publiska diskusija “Eiropas Vēža misijas rekomendāciju aktualitāte Latvijas vēža pacientiem”. Latvijas Universitāte, Rīga, 21.08.2020.
6. Arnis Kiršners. Skolēnu valsts ZPD konferences 2020 dabaszinātnes nozares datorzinātnes un informātikas apakšnozares komisijas loceklis – eksperts. Latvijas Lauksaimniecības Universitāte, Jelgava, 03.04.2020. (pasākums notika attālināti)
7. Arnis Kiršners. Skolēnu reģionālās ZPD konferences 2020 dabaszinātnes nozares datorzinātnes un informātikas apakšnozares komisijas vadītājs un recenzents. Latvijas Universitāte, Rīga, Jelgavas iela 3, 28.02.2020.